Ulinastatin attenuates neuropathic pain via the ATP/P2Y2 receptor pathway in rat models.
Sign Up to like & getrecommendations! Published in 2017 at "Gene"
DOI: 10.1016/j.gene.2017.06.045
Abstract: Ulinastatin, a serine protease inhibitor, which has anti-inflammatory properties and neuroprotective effects, is used to treat acute inflammatory disorders. Recent evidence indicates that administration of ulinastatin alleviates pain in rat model of neuropathic pain (NPP).… read more here.
Keywords: receptor; atp p2y2; p2y2 receptor; receptor pathway ... See more keywords